We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Shedding Light on How Tumors Become Resistant to Immunotherapy

News   Jul 26, 2017 | Original story from University of Zurich

 
Shedding Light on How Tumors Become Resistant to Immunotherapy

The epigenetic control protein Ezh2 plays a central role in how cancer cells develop resistance. (Bild: D. Zingg, UZH)

 
 
 

RELATED ARTICLES

Epigenetic Treatments Could Trigger Aggressive Tumors

News

A team headed by ICREA researchers Salvador Aznar Benitah and Fran Supek concludes that care should be taken with drugs that inhibit epigenetic factors.

READ MORE

Body Scanner Captures 3D Picture of Whole Human Body at Once

News

EXPLORER, the world’s first medical imaging scanner that can capture a 3D picture of the whole human body at once, has produced its first scans.

READ MORE

10-20% of Cells in a Kidney Organoid Found to be Non-Renal

News

Single-cell transcriptomics revealed 10-20% of cells in a kidney organoid were non-renal cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE